...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >Two new point mutations at A2062 associated with resistance to 16-membered macrolide antibiotics in mutant strains of Mycoplasma hominis.
【24h】

Two new point mutations at A2062 associated with resistance to 16-membered macrolide antibiotics in mutant strains of Mycoplasma hominis.

机译:A2062处的两个新点突变与人支原体突变株中对16元大环内酯类抗生素的抗性相关。

获取原文
获取原文并翻译 | 示例

摘要

We describe two mutants of Mycoplasma hominis PG-21 which show resistance to 16-membered macrolides but susceptibility to lincosamides, obtained by in vitro exposure to increasing doses of josamycin. The 23S rRNA gene showed that each had a mutation (A2062G and A2062T) corresponding to nucleotide 2062 in Escherichia coli, which was associated with the acquired phenotype.
机译:我们描述了人型支原体PG-21的两个突变体,它们显示出对16元大环内酯类药物的耐药性,但对林可酰胺类药物的敏感性,是通过体外暴露于不断增加的剂量的沙沙霉素获得的。 23S rRNA基因显示每个都有一个突变(A2062G和A2062T),对应于大肠杆菌中的核苷酸2062,与获得的表型有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号